Results 71 to 80 of about 48,974 (212)
Zihan Zhou,1,2 Dianbin Mu,3 Dexian Zhang,3 Xianbin Zhang,2 Xingchen Ding,2 Jia Yang,2 Xinbin Bai,4 Man Hu2 1Department of Oncology, Weifang Medical University, Weifang, Shandong, People’s Republic of China; 2Department of Radiation Oncology ...
Zhou Z +7 more
doaj
Bitter melon reduces head and neck squamous cell carcinoma growth by targeting c-Met signaling. [PDF]
Head and neck squamous cell carcinoma (HNSCC) remains difficult to treat, and despite of advances in treatment, the overall survival rate has only modestly improved over the past several years.
Ananthi Rajamoorthi +7 more
doaj +1 more source
Review of biomarkers for response to immunotherapy in HNSCC microenvironment
Head and neck squamous cell carcinoma are one of the most common types of cancer worldwide. Although a variety of treatment methods such as surgery, radiotherapy, chemotherapy, and targeted therapy are widely used in diagnosing and treating HNSCC, the survival prognosis of patients has not been significantly improved in the past decades. As an emerging
Shaoshi Chen +5 more
openaire +3 more sources
Copy number percentage of HNSCC patients in TCGA-HNSC cohort.
Copy number percentage of HNSCC patients in TCGA-HNSC cohort.
Lei Zhu (16642) +4 more
core +1 more source
Yitian Lang,1,2 Deshi Dong1,2 1Department of Pharmacy, The First Affiliated Hospital of Dalian Medical University, Dalian, People’s Republic of China; 2College of Pharmacy, Dalian Medical University, Dalian, People’s Republic of ...
Lang Y, Dong D
doaj
miR-149 expression in HNSCC tissues.
(A) Before-and-after plots of the −ΔCt values from paired NCMT tissue, primary HNSCC and neck lymph node metastasis (LN). Paired t-test. (B) ROC analysis across the –ΔΔCt values from survived patients and dead patients.
Chung-Ji Liu (294116) +8 more
core +1 more source
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC [PDF]
Radiotherapy (RT) plus the anti-EGFR monoclonal antibody Cetuximab (CTX) is an effective combination therapy for a subset of head and neck squamous cell carcinoma (HNSCC) patients.
Belletti B. +22 more
core +1 more source
Yu Zhang,1 Lixiao Chen,1 Xiaoliang Wu,2 Zhenfeng Sun,1 Fei Wang,1 Baoxin Wang,1 Pin Dong1 1Department of Otolaryngology, Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ...
Zhang Y +6 more
doaj
Clinical parameters for 687 HPV-negative HNSCC patients.
Clinical parameters for 687 HPV-negative HNSCC patients.
Runze Zhou (17304792) +10 more
core +1 more source
The Mapk-Jun-Tnnt1 Pathway Promotes Proliferation, Metastasis Of Hnscc
Aim or purpose: To validate the role of TNNT1 in the proliferation, invasion, migration, and cytoskeletal remodeling of tongue cancer. Materials and methods: Specific siRNA was used to silence TNNT1 in highly metastatic cells, while a TNNT1 ...
Jing Xie
doaj +1 more source

